Literature DB >> 1933246

Myotonic dystrophy. Predictive value of normal results on clinical examination.

H G Brunner1, H J Smeets, W Nillesen, B A van Oost, J B van den Biezenbos, E M Joosten, A J Pinckers, B C Hamel, A G Theeuwes, B Wieringa.   

Abstract

Myotonic dystrophy (DM) is well known for its highly variable clinical picture, including the age at which symptoms are first detected. In order to assess the proportion of asymptomatic gene carriers at different ages, we have used linked DNA markers to study individuals at 50% genetic risk of DM, in whom neurological examination, slit-lamp examination and electromyography (EMG) had failed to show diagnostic signs. A total of 139 asymptomatic offspring of DM patients were studied. Our analyses identified 11 out of these 139 as probable gene carriers. Our data show that penetrance of the DM gene increases with age. After correction for the possibility of genetic recombination between the DM gene and the DNA markers used, we calculated the residual chance of carrying the DM gene as 8.3% for clinically normal offspring aged between 20 and 39 yrs. We evaluated several factors that might influence this figure. Neither the sex of the propositus nor that of the affected parent modified the risk of carrying the DM gene. Presence of aspecific lens opacities also did not correlate with the risk of having inherited the DM gene. Since a significant proportion of DM gene carriers are not detected by neurological examination, including slit-lamp examination and EMG, these results confirm the need for DNA analysis in asymptomatic offspring of DM patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933246     DOI: 10.1093/brain/114.5.2303

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  9 in total

1.  Instability versus predictability: the molecular diagnosis of myotonic dystrophy.

Authors:  G K Suthers; S M Huson; K E Davies
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

2.  Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM).

Authors:  H G Brunner; H T Brüggenwirth; W Nillesen; G Jansen; B C Hamel; R L Hoppe; C E de Die; C J Höweler; B A van Oost; B Wieringa
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

3.  Cataract and myotonic dystrophy: the role of molecular diagnosis.

Authors:  W Reardon; J C MacMillan; J Myring; H G Harley; S A Rundle; L Beck; P S Harper; D J Shaw
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

4.  Presymptomatic diagnosis of myotonic dystrophy.

Authors:  H G Brunner; W Nillesen; B A van Oost; G Jansen; B Wieringa; H H Ropers; H J Smeets
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

5.  Minimal expression of myotonic dystrophy: a clinical and molecular analysis.

Authors:  W Reardon; H G Harley; J D Brook; S A Rundle; S Crow; P S Harper; D J Shaw
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

6.  Influence of the sex of the transmitting grandparent in congenital myotonic dystrophy.

Authors:  A López de Munain; A M Cobo; J J Poza; D Navarrete; L Martorell; F Palau; J I Emparanza; M Baiget
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

7.  Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family.

Authors:  C E de Die-Smulders; C J Höweler; J F Mirandolle; H G Brunner; V Hovers; H Brüggenwirth; H J Smeets; J P Geraedts
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

8.  Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy.

Authors:  H G Harley; S A Rundle; J C MacMillan; J Myring; J D Brook; S Crow; W Reardon; I Fenton; D J Shaw; P S Harper
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

9.  Origin of a regressed myotonic dystrophy allele.

Authors:  M Giordano; M S De Angelis; R Mutani; P M Richiardi
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.